Patient-specific murine I-131-labeled anti-tenascin monoclonal antibody 81C6 radioimmunotherapy for delivering a 44-GY boost to the resection cavity periphery of patients with newly diagnosed primary malignant brain tumors: A feasibility pilot study


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Reardon, D; Akabani, G; Friedman, A; Friedman, H; Herndon, J; McLendon, R; Quinn, J; Rich, J; Vredenburga, J; Dejardins, A; Sampson, J; Gururangan, S; Kirkpatrick, J; Wong, T; Dowell, J; Dunn, R; Sathornsumettee, S; Boutlton, S; Coleman, R; Zalutsky, M; Bigner, D

Published Date

  • October 1, 2006

Published In

Volume / Issue

  • 8 / 4

Start / End Page

  • 489 - 489

Published By


  • 1

International Standard Serial Number (ISSN)

  • 1522-8517

Conference Name

  • 7th Congress of the European-Association-for-Neuro-Oncology (EANO)

Conference Location

  • Vienna, AUSTRIA

Conference Start Date

  • September 14, 2006

Conference End Date

  • September 17, 2006